首页 > 最新文献

Medical Letter on Drugs and Therapeutics最新文献

英文 中文
Comparison Table: Some Topical Drugs for Rosacea. 对照表:一些治疗红斑痤疮的外用药物
IF 1.9 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701f
{"title":"Comparison Table: Some Topical Drugs for Rosacea.","authors":"","doi":"10.58347/tml.2024.1701f","DOIUrl":"https://doi.org/10.58347/tml.2024.1701f","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1701","pages":"e73-e74"},"PeriodicalIF":1.9,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lifileucel (Amtagvi): A cellular therapy for melanoma. Lifileucel(Amtagvi):一种治疗黑色素瘤的细胞疗法。
IF 1.4 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701h
{"title":"Lifileucel (Amtagvi): A cellular therapy for melanoma.","authors":"","doi":"10.58347/tml.2024.1701h","DOIUrl":"10.58347/tml.2024.1701h","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1701","pages":"e77-e78"},"PeriodicalIF":1.4,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A new indication for semaglutide (Wegovy). semaglutide(Wegovy)的新适应症。
IF 1.9 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701b
{"title":"A new indication for semaglutide (Wegovy).","authors":"","doi":"10.58347/tml.2024.1701b","DOIUrl":"https://doi.org/10.58347/tml.2024.1701b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1701","pages":"66-67"},"PeriodicalIF":1.9,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
iDose TR - a travoprost implant for glaucoma. iDose TR - 一种用于青光眼的曲伏前列素植入物。
IF 1.9 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701d
{"title":"iDose TR - a travoprost implant for glaucoma.","authors":"","doi":"10.58347/tml.2024.1701d","DOIUrl":"https://doi.org/10.58347/tml.2024.1701d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1701","pages":"70-71"},"PeriodicalIF":1.9,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140853641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Belzutifan (Welireg) for advanced renal cell carcinoma. 贝珠替凡(Welireg)治疗晚期肾细胞癌。
IF 1.9 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701g
{"title":"Belzutifan (Welireg) for advanced renal cell carcinoma.","authors":"","doi":"10.58347/tml.2024.1701g","DOIUrl":"https://doi.org/10.58347/tml.2024.1701g","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1701","pages":"e75-e76"},"PeriodicalIF":1.9,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic prophylaxis for dental procedures. 牙科手术的抗生素预防。
IF 1.9 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701e
{"title":"Antibiotic prophylaxis for dental procedures.","authors":"","doi":"10.58347/tml.2024.1701e","DOIUrl":"10.58347/tml.2024.1701e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1701","pages":"71-72"},"PeriodicalIF":1.9,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140872738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resmetirom (Rezdiffra) for metabolic dysfunction-associated steatohepatitis. Resmetirom(Rezdiffra)治疗代谢功能障碍相关性脂肪性肝炎。
IF 1.9 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-29 DOI: 10.58347/tml.2024.1701a
{"title":"Resmetirom (Rezdiffra) for metabolic dysfunction-associated steatohepatitis.","authors":"","doi":"10.58347/tml.2024.1701a","DOIUrl":"10.58347/tml.2024.1701a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1701","pages":"65-66"},"PeriodicalIF":1.9,"publicationDate":"2024-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140868282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cabtreo: A three-drug gel for acne. Cabtreo:治疗痤疮的三药凝胶
IF 1.9 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-15 DOI: 10.58347/tml.2024.1700b
{"title":"Cabtreo: A three-drug gel for acne.","authors":"","doi":"10.58347/tml.2024.1700b","DOIUrl":"https://doi.org/10.58347/tml.2024.1700b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1700","pages":"59-60"},"PeriodicalIF":1.9,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140867834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Roflumilast foam (Zoryve) for seborrheic dermatitis. 治疗脂溢性皮炎的罗氟司特泡沫剂(Zoryve)。
IF 1.9 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-15 DOI: 10.58347/tml.2024.1700a
{"title":"Roflumilast foam (Zoryve) for seborrheic dermatitis.","authors":"","doi":"10.58347/tml.2024.1700a","DOIUrl":"https://doi.org/10.58347/tml.2024.1700a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1700","pages":"57-59"},"PeriodicalIF":1.9,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140872023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zilucoplan (Zilbrysq) for myasthenia gravis. 治疗重症肌无力的 Zilucoplan(Zilbrysq)。
IF 1.9 4区 医学 Q4 PHARMACOLOGY & PHARMACY Pub Date : 2024-04-15 DOI: 10.58347/tml.2024.1700c
{"title":"Zilucoplan (Zilbrysq) for myasthenia gravis.","authors":"","doi":"10.58347/tml.2024.1700c","DOIUrl":"https://doi.org/10.58347/tml.2024.1700c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"66 1700","pages":"60-62"},"PeriodicalIF":1.9,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140854445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medical Letter on Drugs and Therapeutics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1